Myburgh Corrie, Kildsgaard Katrine, Damsgaard Thomas, Corfixen Kim, Boyle Eleanor
Department of Sports Science and Clinical Biomechanics, Odense, Denmark.
Department of Sports Science and Clinical Biomechanics, Odense, Denmark.
J Manipulative Physiol Ther. 2021 Sep;44(7):546-557. doi: 10.1016/j.jmpt.2021.12.004.
The purpose of this study was to systematically explore the reporting of trigger-point dry needling (DN) in high-quality randomized clinical trials (RCTs) and to evaluate those trials' intervention fidelity.
A focused systematic review and meta-analysis was conducted. PubMed and Cochrane databases were searched for systematic reviews focusing on DN, published from January 2014 to January 2019. Randomized clinical trials with a low risk of bias were identified and their reported intervention data extracted. Dry-needling interventions were categorized according to common technique elements, and the Template for Intervention Description and Replication (TIDieR) was used to appraise their intervention fidelity.
Fifteen systematic reviews were identified, and from these we extracted data from 26 RCTs. Twelve unique technique descriptors were identified, and 8 technique archetype categories were distinguishable, based on whether a local twitch response defined the start of the intervention, whether continuous needle insertion and withdrawal was used, and what criteria determined the cessation of needling. The median number of TIDieR items reported was 8.5 out of 12. Explicit procedure reporting was uncommon for intervention tailoring (38%) and rare for intervention mode (19%) and modifications (7%).
Across the RCTs included in this review, substantial heterogeneity in the choice and reporting of DN was evident. In particular, systematic underreporting of intervention tailoring, mode clarification, and procedure modification undermined intervention fidelity. The development and adoption of standardized intervention guidelines is recommended to enhance uniform and nuanced reporting of DN interventions.
本研究旨在系统探讨高质量随机临床试验(RCT)中触发点干针疗法(DN)的报告情况,并评估这些试验的干预保真度。
进行了一项针对性的系统评价和荟萃分析。检索了PubMed和Cochrane数据库,以查找2014年1月至2019年1月发表的聚焦于DN的系统评价。识别出偏倚风险较低的随机临床试验,并提取其报告的干预数据。根据常见技术要素对干针干预进行分类,并使用干预描述与复制模板(TIDieR)来评估其干预保真度。
识别出15项系统评价,从中我们提取了26项RCT的数据。确定了12种独特的技术描述符,基于局部抽搐反应是否定义干预开始、是否使用连续进针和退针以及确定停止针刺的标准,可区分出8种技术原型类别。报告的TIDieR项目中位数为12项中的8.5项。干预调整的明确程序报告不常见(38%),干预模式(19%)和修改(7%)的报告则很少见。
在本综述纳入的RCT中,DN的选择和报告存在明显的异质性。特别是,干预调整、模式说明和程序修改的系统性报告不足破坏了干预保真度。建议制定并采用标准化干预指南,以加强DN干预的统一和细致报告。